Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Cancer treatment using peptides: current therapies and future prospects.

Thundimadathil J.

J Amino Acids. 2012;2012:967347. doi: 10.1155/2012/967347. Epub 2012 Dec 20.

PMID:
23316341
[PubMed]
Free PMC Article
2.

The Challenge of Developing New Therapies for Childhood Cancers.

Balis FM.

Oncologist. 1997;2(1):I-II.

PMID:
10388032
[PubMed - as supplied by publisher]
3.

The Goal of Cancer Treatment.

Balis FM.

Oncologist. 1998;3(4):V.

PMID:
10388118
[PubMed - as supplied by publisher]
4.

Peptides for diagnosis and treatment of colorectal cancer.

Shapira S, Fokra A, Arber N, Kraus S.

Curr Med Chem. 2014;21(21):2410-6.

PMID:
24524764
[PubMed - in process]
5.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
6.

Anticancer Drug Development: The Way Forward.

Connors T.

Oncologist. 1996;1(3):180-181.

PMID:
10387985
[PubMed - as supplied by publisher]
Free Article
7.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
8.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
[PubMed - indexed for MEDLINE]
9.

Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.

Aguilar LK, Guzik BW, Aguilar-Cordova E.

J Cell Biochem. 2011 Aug;112(8):1969-77. doi: 10.1002/jcb.23126. Review.

PMID:
21465529
[PubMed - indexed for MEDLINE]
10.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
11.

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

Schally AV, Nagy A.

Eur J Endocrinol. 1999 Jul;141(1):1-14. Review.

PMID:
10407215
[PubMed - indexed for MEDLINE]
Free Article
12.

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.

Baxevanis CN, Perez SA, Papamichail M.

Cancer Immunol Immunother. 2009 Mar;58(3):317-24. doi: 10.1007/s00262-008-0576-4. Epub 2008 Aug 15. Review.

PMID:
18704409
[PubMed - indexed for MEDLINE]
13.

Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Curr Pharm Des. 2000 Feb;6(3):261-76. Review.

PMID:
10637379
[PubMed - indexed for MEDLINE]
14.

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.

Cirak Y, Varol U, Atmaca H, Kisim A, Sezgin C, Karabulut B, Uzunoglu S, Uslu R, Karaca B.

BJU Int. 2012 Dec;110(11 Pt C):E1147-54. doi: 10.1111/j.1464-410X.2012.11392.x. Epub 2012 Aug 9.

PMID:
22882676
[PubMed - indexed for MEDLINE]
15.

The biology of hormone refractory prostate cancer. Why does it develop?

Isaacs JT.

Urol Clin North Am. 1999 May;26(2):263-73. Review.

PMID:
10361549
[PubMed - indexed for MEDLINE]
16.

Combining Vaccines with Conventional Therapies for Cancer.

Arlen PM, Madan RA, Hodge JW, Schlom J, Gulley JL.

Update Cancer Ther. 2007 Mar;2(1):33-39.

PMID:
17948067
[PubMed]
Free PMC Article
17.

Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer.

Tkaczuk KH.

Clin Ther. 2009;31 Pt 2:2273-89. doi: 10.1016/j.clinthera.2009.11.011. Review.

PMID:
20110041
[PubMed - indexed for MEDLINE]
18.

INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.

[No authors listed]

BioDrugs. 2003;17(3):216-22. Review.

PMID:
12749760
[PubMed - indexed for MEDLINE]
19.

New molecular targets of breast cancer therapy.

Sauer G, Deissler H, Kurzeder C, Kreienberg R.

Strahlenther Onkol. 2002 Mar;178(3):123-33. Review.

PMID:
11962188
[PubMed - indexed for MEDLINE]
20.

[Current trends in pharmacotherapy of breast cancer].

Boér K.

Orv Hetil. 2002 Apr 7;143(14):725-30. Review. Hungarian.

PMID:
11975393
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk